Ategrity Specialty Insurance Co Holdings (ASIC) Market Cap & Valuation Ratios
Ategrity Specialty Insurance Co Holdings (ASIC) has a market cap of $1.2B, a trailing P/E of 11.2 and a price-to-sales ratio of 2.2, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ASICAtegrity Specialty Insurance Co HoldingsFollow ASIC — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- 11.2
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 21 Oct, in -3 days
Peers
insurance - property & casualty · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | P/B | ROE | Div. yield | Rev. growth |
|---|---|---|---|---|---|---|
| ASIC | 1.2 | 11.2 | 1.74 | 17% | 0.0% | +37% |
| KMPR | 1.7 | — | 0.77 | -39% | 4.4% | -4% |
| SAFT | 1.5 | 22.4 | 1.74 | 8% | 3.5% | +7% |
| UFCS | 1.5 | 10.7 | 1.51 | 15% | 1.3% | +11% |
| UVE | 1.4 | 6.4 | 2.13 | 40% | 1.6% | +4% |
| STC | 1.3 | 9.6 | 0.81 | 9% | 4.8% | +22% |
| TRUP | 1.3 | 55.3 | 3.14 | 6% | — | +12% |
| BOW | 1.1 | 18.4 | 2.37 | 14% | — | +25% |
| HRTG | 1.1 | 5.2 | 1.93 | 45% | — | +2% |
| HIPO | 1.0 | — | 2.18 | 30% | — | +19% |
| ROOT | 0.8 | 14.9 | 2.50 | 21% | — | +15% |
| Median of these 10 | 12.8 | 2.03 | 15% | 3.5% | +12% |
P/E 11.2 vs. a peer median of 12.8; P/B 1.74 vs. 2.03.
Growth vs. price
each dot a company · hover or tap for valuesKMPR and HIPO have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Ategrity Specialty Insurance Co Holdings — questions
- What is Ategrity Specialty Insurance Co Holdings's market cap?
- $1.2B.
- What is Ategrity Specialty Insurance Co Holdings's P/E ratio?
- 11.2 on trailing twelve-month earnings to 2026-06-30.
- What is Ategrity Specialty Insurance Co Holdings's price-to-sales ratio?
- 2.2.
Every figure on this page comes from Ategrity Specialty Insurance Co Holdings's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.